Form D · Private Equity Fund
OrbiMed Royalties IV Private Investors, LLC
New York, NY · CIK 0001948473
Offering snapshot reported May 8, 2023 · SEC filing
- Reported sold
- $70.6M Indefinite offering
- Investors reported
- 88 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Dec 7, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$38,450,000 → $70,550,000
- Reported investors56 → 88
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2023 | Amendment | $70,550,000 | $32,100,000vs Dec 20, 2022 | 88 | SEC filing |
| Dec 20, 2022 | Initial | $38,450,000 | No comparison | 56 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $915K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-468038
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None | J.P. Morgan Securities LLC · CRD 79 |
Source: Form D, filed May 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grant Cellier | Director |
| N/A J.P. Morgan Private Investments Inc. | Executive, Promoter |
| Richard Ruffer | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10179